The Effects of Patient Features on Opioid Induced End-Tidal CO2
Information source: Albany Medical College
Information obtained from ClinicalTrials.gov on February 07, 2013
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Opioid Use During Medical Care
Sponsored by: Albany Medical College
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or
Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.
Official title: The Effect of Patient Features on Opioid Induced End-Tidal CO2
Study design: Observational Model: Cohort, Time Perspective: Prospective
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or
Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will
be placed between the upper lip and nose. This tube is used to measure the amount of carbon
dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider
feels the patient needs it. The carbon dioxide breathed out is measured and collected.
Other information collected are height, weight, and vital signs. Patient participation time
is approximately 2 hours during the emergency department visit.
Minimum age: 18 Years.
Maximum age: N/A.
- non intubated patients receiving intravenous opioid medications
- mechanically ventilated patients
- patients with physiologic shock
Locations and Contacts
Albany Medical Center Emergency Department, Albany, New York 12208, United States; Recruiting
Wayne Triner, DO, Phone: 518-262-3773, Email: email@example.com
Nancy Robak, RN, MPH, Phone: 518-262-3773, Email: firstname.lastname@example.org
Howard Smith, MD, Sub-Investigator
Starting date: August 2010
Last updated: June 10, 2011